- Home
- BHFAO vs SNN Comparison
BHFAO vs SNN Comparison
Compare BHFAO & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHFAO
- SNN
- Stock Information
- Founded
- BHFAO N/A
- SNN 1856
- Country
- BHFAO United States
- SNN United Kingdom
- Employees
- BHFAO 1400
- SNN N/A
- Industry
- BHFAO Life Insurance
- SNN Industrial Specialties
- Sector
- BHFAO Finance
- SNN Health Care
- Exchange
- BHFAO Nasdaq
- SNN Nasdaq
- Market Cap
- BHFAO N/A
- SNN 15.2B
- IPO Year
- BHFAO N/A
- SNN 1999
- Fundamental
- Price
- BHFAO $16.38
- SNN $32.92
- Analyst Decision
- BHFAO
- SNN Hold
- Analyst Count
- BHFAO 0
- SNN 4
- Target Price
- BHFAO N/A
- SNN $32.83
- AVG Volume (30 Days)
- BHFAO N/A
- SNN 578.1K
- Earning Date
- BHFAO N/A
- SNN 10-30-2025
- Dividend Yield
- BHFAO N/A
- SNN 2.22%
- EPS Growth
- BHFAO N/A
- SNN 59.91
- EPS
- BHFAO N/A
- SNN 0.56
- Revenue
- BHFAO N/A
- SNN $5,944,000,000.00
- Revenue This Year
- BHFAO N/A
- SNN N/A
- Revenue Next Year
- BHFAO N/A
- SNN N/A
- P/E Ratio
- BHFAO N/A
- SNN $58.98
- Revenue Growth
- BHFAO N/A
- SNN 5.35
- 52 Week Low
- BHFAO N/A
- SNN $23.69
- 52 Week High
- BHFAO N/A
- SNN $38.79
- Technical
- Relative Strength Index (RSI)
- BHFAO 49.79
- SNN 39.07
- Support Level
- BHFAO $15.29
- SNN $31.95
- Resistance Level
- BHFAO $16.57
- SNN $32.92
- Average True Range (ATR)
- BHFAO 0.53
- SNN 0.52
- MACD
- BHFAO -0.03
- SNN -0.15
- Stochastic Oscillator
- BHFAO 37.86
- SNN 21.05
About BHFAO Brighthouse Financial Inc. Depositary Shares 6.75% Non-Cumulative Preferred Stock Series B
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About SNN Smith & Nephew SNATS Inc.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.